KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,802,411 | -22.3% | 176,252 | -0.3% | 1.75% | -18.0% |
| Q2 2023 | $38,344,818 | +803.1% | 176,826 | +656.5% | 2.13% | +12.9% |
| Q1 2023 | $4,245,835 | +22.1% | 23,375 | +32.1% | 1.89% | +12.0% |
| Q4 2022 | $3,478,050 | -12.6% | 17,700 | 0.0% | 1.69% | -15.0% |
| Q3 2022 | $3,981,000 | +63.0% | 17,700 | -8.3% | 1.99% | +83.5% |
| Q2 2022 | $2,442,000 | +8.2% | 19,300 | +8.4% | 1.08% | +41.4% |
| Q1 2022 | $2,257,000 | -10.3% | 17,800 | -7.3% | 0.76% | +5.5% |
| Q4 2021 | $2,515,000 | – | 19,200 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |